Long-term exposure to PFE-360 in the AAV-α-synuclein rat model: findings and implications
Michael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, Lassina Badolo, Ross Jeggo, Garrick Paul Smith, Kenneth Vielsted Christensen
This study investigates the long-term effects of PFE-360 treatment in an AAV-α-synuclein rat model to assess its potential as a LRRK2 inhibitor for Parkinson's disease.
eNeuro · Nov 1, 2019Peer-reviewedNeuroscience